ACHIKO N/ CH0522213468 /
2023-10-26 10:10:00 PM | Chg. - | Volume | Bid2023-10-25 | Ask2023-10-25 | High | Low |
---|---|---|---|---|---|---|
0.0004CHF | - | - Turnover: - |
-Bid Size: 0 | -Ask Size: 0 | 0.0004 | 0.0004 |
GlobeNewswire
2022-01-27
Achiko AG Strengthens Senior Team with Appointment of Head of Corporate Development
GlobeNewswire
2022-01-18
Achiko AG Announces Feature Article on “How We Get Back to Normal” with its AptameX™ Covid-19 Rapid ...
GlobeNewswire
2022-01-14
Achiko AG Reports Breakthrough Calibration Results for its AptameX™ Covid-19 Rapid Test Technology
GlobeNewswire
2021-12-23
Achiko AG Looks Back at Pivotal Year and Reaffirms Commitment to Provide Affordable and Accurate COV...
GlobeNewswire
2021-12-08
Achiko’s Commercialization Update: Optimized Second-Generation Covid-19 Diagnostic Test Receives Ful...
GlobeNewswire
2021-08-25
Achiko’s Rapid Covid-19 Diagnostic Test AptameX™ Receives Product and Registration Approval from Ind...
GlobeNewswire
2021-07-15
Achiko Engages EpiMetrics to Expand Covid-19 Testing Operations with Udayana University in Bali, Ind...
GlobeNewswire
2021-07-13
Achiko Working Towards a Solution for Frequent Global Mass COVID-19 Testing
GlobeNewswire
2021-06-18
Achiko Announces an Extension of its Convertible Loan Transaction with Negma Group
GlobeNewswire
2021-06-03
Achiko Announces the Successful Integration of its Teman Sehat Digital Ecosystem and AptameX Covid-1...
GlobeNewswire
2021-06-03
Achiko AG Announces Successful Integration of its Teman Sehat Digital Ecosystem and AptameX Covid-19...
GlobeNewswire
2021-05-20
Achiko Completes Initial Shipment of AptameX, its Progressive Covid-19 Diagnostic Test to Indonesia,...
GlobeNewswire
2021-05-04
Achiko Appoints New Chief Financial Officer and Announces Changes to Senior Team